Bullous pemphigoid associated with milia, increased serum IgE, autoantibodies against desmogleins, and refractory treatment in a young patient

AUTOR(ES)

Ding, Shu, Deng, Qiancheng, Xiang, Yaping, Chen, Jing, Huang, Jinhua, Lu, Jianyun

FONTE

An. Bras. Dermatol.

DATA DE PUBLICAÇÃO

2017

RESUMO

Abstract: Bullous pemphigoid is a blistering autoimmune disease characterized by two hemidesmosomal proteins (anti-BP180 and 230). Pemphigus, by contrast, is characterized by two autoantibodies (anti-desmoglein 1 and 3). Coexistence of autoantibodies of bullous pemphigoid and pemphigus in a patient is rare. A 25-year-old male patient was admitted to our hospital, reporting a 3-month history of multiple papules, vesicles, and erosions over an extensive erythema on the entire body. Laboratory tests showed high levels of serum IgE, anti-BP180 antibodies, and anti-desmoglein 1 and 3. Histopathologic and immunopathologic features were characterized by bullous pemphigoid. No improvement was seen with systemic corticosteroid therapy, however, pulse corticosteriod therapy combined with methylprednisolone, immunosuppressants, immunomodulators, and plasmapheresis led to the recovery of his condition with numerous milia.

Documentos Relacionados

• Unilateral ocular cicatricial pemphigoid with circulating IgA and IgG autoantibodies reactive with the 180 kD bullous pemphigoid antigen.
• Corticosteroids, IgE, and atopy
• Increased serum IgE level and interleukin-4 release from cultured lymphocytes from a patient with adult onset Still's disease.
• Bullous pemphigoid and milia: prevalence and clinical laboratory findings in a Brazilian sample
• IgE, Mast Cells and the Allergic Response